Established in February 2005, NIDA's AIDS Research Program (ARP) supports the development, planning, and coordination of high priority research on HIV/AIDS and drug abuse within NIDA as well as across NIH Institutes and other DHHS agencies. ARP ensures that there an integrated vision and strategy to guide HIV/AIDS research throughout NIDA that is responsive to the evolving nature of HIV/AIDS disease among drug users in the . and internationally and that meets the goals of the National HIV/AIDS Strategy https:///federal-resources/national-hiv-aids-strategy/overview/ and NIH HIV/AIDS Research Priorities http:///grants/guide/notice-files/NOT-OD-15- . The FY18 Trans-NIH Plan for HIV-Related Research https:///strategic_plan/fy2018/OAR_18_StrategicPlan_P10_ provides additional information on NIH HIV/AIDS high priority research.
Around fifth part of the injected steroid binds to progestin receptors (due to the absence of a carbon atom in the 19 position), and therefore, such reactions as the suppression of secretion of gonadotropin-releasing hormone, increased production of prolactin, a significant decrease in libido should not be excluded. Weak erection - the most pronounced and severe consequence of abuse of deca nandrolone. Exceeding of the recommended dosage and duration of the course may cause rhinitis, headache, back pain, rash. In general, the side effects of nortestosterone decanoate - rather the exception than the rule.